JPRN-jRCTs071210130
Recruiting
未知
Study of the effect of pemafibrate on thrombus forming ability in patients with dyslipidemia with a history of coronary artery disease
Tsujita Kenichi0 sites100 target enrollmentMarch 7, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Dyslipidemia with a history of coronary artery disease
- Sponsor
- Tsujita Kenichi
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Age\>\=20, regardless of gender
- •2\)History of coronary artery disease
- •3\)150mg/dL\<\= fasting or occasional TG\<500mg/dL within 3 months before informed
- •4\)LDL\-C\<100mg/dL within 3 months before
- •informed consent
- •5\)Under receiving of statin without changing the
- •type and the dose more than 3 months before
- •informed consent
- •6\)Under receiving of a single antiplatelet drug without changing the type and the dose more than 14 days at the time of Visit 0
- •7\) Written consent for participation to this study
Exclusion Criteria
- •1\)Subjects to whom the study drugs are contraindicated in the package inserts
- •2\)Subjects who developed acute coronary
- •syndrome within the past 3 months from the day
- •of the consent acquisition
- •3\)serum\-Cr\>\=1\.5mg/dL
- •4\)Under receiving of fibrates or omega 3 fatty acid preparations or equivalent supplements within 3 months before informed consent
- •5\)Under receiving of anticoagulants within 7 days before informed consent,or with plans
- •6\)With plans for major surgery with a blood
- •transfusion
- •7\)Under receiving of antiplatelet drug treatment other than aspirin, clopidogrel, and prasugrel
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100
Not yet recruiting
Not Applicable
Effect of pemafibrate on hemorheology in microvessels in patients with hypertriglyceridemia associated with type 2 diabetes mellitus or metabolic syndromemetabolic syndrome, Hypertriglycdimia, Diabetes mellitusJPRN-UMIN000040009Dokkyo Medical University Nikko Medical Center Department of cardiology medicine and nephrology50
Recruiting
Not Applicable
Interventional study on the reduction of thrombus using rivaroxaban for deep vein thrombosis and pulmonary thromboembolismvenous thromboembolismJPRN-UMIN000032996Toho University40
Recruiting
Phase 2
Pemafibrate and coronary plaque characteristicsJPRN-jRCTs051190100ogi Kazutaka20
Completed
Not Applicable
Impact of Pemafibrate on coronary plaque characteristics in ACS patientsACS patients who underwent OCT guided PCIJPRN-UMIN000034434ara Medical University20